HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Burns, T. Search for Related Content PubMed Articles by Burns, T.

Hospitalisation as an outcome measure in schizophrenia

Social Psychiatry, University Department of Psychiatry, Warneford Hospital, Headington, Oxford OX3 7JZ, UK. Email: Tom.burns{at}psych.ox.ac.uk

Declaration of interest T.B. has received payments for lectures and consultancies from Eli Lilly, Janssen and Otsuka in the past 5 years.

Background People with schizophrenia comprise the majority of patients with severe mental illness recruited to recent mental health service studies of new teams (e.g. assertive outreach, crisis resolution). Reduction in hospitalisation has been the most consistent outcome measure in these studies, but results are inconsistent.

Aims To understand inconsistency of results from studies using hospitalisation as an outcome measure.

Method The advantages and disadvantages of hospitalisation are explored, including the ways in which it is recorded. Regional variation in outcomes and the impact of control services are reviewed.

Results Hospitalisation has face validity as an outcome buttranslates poorly between differing healthcare contexts. These variations can be exploited positively to distinguish potentially effective ingredients in community care (outreach, combined health and social care, team structure) from redundant components.

Conclusions Hospitalisation is a good proxy outcome measure in schizophrenia care in randomised controlled trials, but the dangers of extrapolating to new contexts require care.

This article has been cited by other articles:

				T. Burns Evolution of outcome measures in schizophrenia The British Journal of Psychiatry, August 1, 2007; 191(50): s1 - s6. [Abstract] [Full Text] [PDF]

				M. Isaac, P. Chand, and P. Murthy Schizophrenia outcome measures in the wider international community The British Journal of Psychiatry, August 1, 2007; 191(50): s71 - s77. [Abstract] [Full Text] [PDF]